Profile data is unavailable for this security.
About the company
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
- Revenue in GBP (TTM)272.00k
- Net income in GBP-5.00m
- Incorporated2007
- Employees43.00
- LocationGenedrive PLC48 Grafton StreetMANCHESTER M13 9XXUnited KingdomGBR
- Phone+44 16 1989 0245Fax+44 16 1989 0262
- Websitehttp://www.genedriveplc.com/
Peer analysis
Company | Revenue (TTM) | Net income (TTM) |
---|---|---|
Surgical Innovations Group Plc | 12.01m | -509.00k |
Myhealthchecked PLC | 10.98m | -159.00k |
Rua Life Sciences PLC | 1.87m | -1.87m |
Cambridge Nutritional Sciences PLC | 9.05m | -3.21m |
Feedback plc | 886.00k | -3.49m |
Genedrive PLC | 272.00k | -5.00m |
Proteome Sciences plc | 5.03m | -2.44m |
Inspiration Healthcare Group PLC | 37.63m | -6.32m |
Genincode PLC | 2.16m | -7.02m |
Abingdon Health PLC | 5.34m | -2.24m |
Institutional shareholders
Holder | Shares | % Held |
---|---|---|
Peel Hunt LLPas of 24 Jun 2024 | 54.27m | 17.58% |
Hargreaves Lansdown Asset Management Ltd.as of 01 Jan 2022 | 5.48m | 1.78% |
Jarvis Investment Management Ltd.as of 14 Jun 2023 | 2.95m | 0.96% |
IG Markets Ltd.as of 01 Jan 2022 | 2.74m | 0.89% |
Rathbones Investment Management Ltd.as of 01 Jan 2022 | 2.35m | 0.76% |
HSBC Global Asset Management (UK) Ltd.as of 01 Jan 2022 | 2.21m | 0.71% |
BGF Investment Management Ltd.as of 05 Feb 2021 | 1.91m | 0.62% |
Walker Crips Investment Management Ltd.as of 01 Jan 2022 | 1.90m | 0.61% |
M&G Investment Management Ltd.as of 05 Feb 2020 | 1.76m | 0.57% |
Unicorn Asset Management Ltd.as of 30 Jun 2024 | 1.15m | 0.37% |